日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Integration of PET/CT parameters and a clinical variable to predict the risk of progression of disease within 24 months (POD24) in follicular lymphoma

整合PET/CT参数和临床变量预测滤泡性淋巴瘤24个月内疾病进展风险（POD24）

期刊:Quantitative Imaging in Medicine and Surgery
影响因子:2.3
doi:10.21037/qims-24-1504
Jiang, Qiuhui; Lin, Zhijuan; Chen, Qinwei; Lin, Feng; Jiang, Chong; Deng, Manman; Zha, Jie; Liu, Long; Ding, Chongyang; Xu, Bing
淋巴瘤
发表日期：2025
文献求助 收藏

Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways

雷公藤内酯醇和MDM2抑制剂通过调节p53依赖性和非依赖性通路对急性髓系白血病产生治疗协同作用

期刊:Experimental Hematology & Oncology
影响因子:13.5
doi:10.1186/s40164-022-00276-z
Chen, Qinwei; Deng, Suqi; Deng, Manman; Shi, Yuanfei; Zhong, Mengya; Ding, Lihong; Jiang, Yuelong; Zhou, Yong; Carter, Bing Z; Xu, Bing
白血病
信号转导
MDM2
发表日期：2022
文献求助 收藏

Clinical features and outcomes of 1845 patients with follicular lymphoma: a real-world multicenter experience in China

中国1845例滤泡性淋巴瘤患者的临床特征和预后：一项真实世界多中心研究

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-021-01139-6
Zha, Jie; Fan, Liyuan; Yi, Shuhua; Yu, Haifeng; Zheng, Zhong; Xu, Wei; Deng, Manman; Lin, Zhijuan; Li, Zhifeng; Ping, Lingyan; He, Xiaohua; Chen, Feili; Xie, Ying; Chen, Biyun; Zhang, Huilai; Wang, Li; Ding, Kaiyang; Li, Wenyu; Yang, Haiyan; Zhao, Weili; Qiu, Lugui; Li, Zhiming; Song, Yuqin; Xu, Bing
淋巴瘤
发表日期：2021
文献求助 收藏

Molecular and genetic biomarkers implemented from next-generation sequencing provide treatment insights in clinical practice for Waldenström macroglobulinemia

利用新一代测序技术获得的分子和遗传生物标志物为华氏巨球蛋白血症的临床治疗提供了新的思路。

期刊:Neoplasia
影响因子:7.7
doi:10.1016/j.neo.2021.02.002
Wang, Yingjun; Gali, Vasantha Lakshmi; Xu-Monette, Zijun Y; Sano, Dahlia; Thomas, Sheeba K; Weber, Donna M; Zhu, Feng; Fang, Xiaosheng; Deng, Manman; Zhang, Mingzhi; Hagemeister, Fredrick B; Li, Yong; Orlowski, Robert Z; Lee, Hans Chulhee; Young, Ken H
Sequencing
发表日期：2021
文献求助 收藏

Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents

具有MYC/TP53双重改变的侵袭性B细胞淋巴瘤表现出独特的临床病理生物学特征和对新型靶向药物的反应

期刊:Molecular Cancer Research
影响因子:4.7
doi:10.1158/1541-7786.MCR-20-0466
Deng, Manman; Xu-Monette, Zijun Y; Pham, Lan V; Wang, Xudong; Tzankov, Alexandar; Fang, Xiaosheng; Zhu, Feng; Visco, Carlo; Bhagat, Govind; Dybkaer, Karen; Chiu, April; Tam, Wayne; Zu, Youli; Hsi, Eric D; You, Hua; Huh, Jooryung; Ponzoni, Maurilio; Ferreri, Andrés J M; Møller, Michael B; Parsons, Benjamin M; Hagemeister, Fredrick; van Krieken, J Han; Piris, Miguel A; Winter, Jane N; Li, Yong; Xu, Bing; Liu, Phillip; Young, Ken H
B细胞
淋巴瘤
P53
细胞生物学
MYC
免疫/内分泌
发表日期：2021
文献求助 收藏

XPO1 expression worsens the prognosis of unfavorable DLBCL that can be effectively targeted by selinexor in the absence of mutant p53

XPO1表达会加重预后不良的弥漫性大B细胞淋巴瘤（DLBCL）的病情，而当不存在突变型p53时，塞利尼索（selinexor）可有效靶向治疗DLBCL。

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-020-00982-3
Deng, Manman; Zhang, Mingzhi; Xu-Monette, Zijun Y; Pham, Lan V; Tzankov, Alexandar; Visco, Carlo; Fang, Xiaosheng; Bhagat, Govind; Zhu, Feng; Dybkaer, Karen; Chiu, April; Tam, Wayne; Zu, Youli; Hsi, Eric D; Choi, William W L; Huh, Jooryung; Ponzoni, Maurilio; Ferreri, Andrés J M; Møller, Michael B; Parsons, Benjamin M; van Krieken, J Han; Piris, Miguel A; Winter, Jane N; Hagemeister, Fredrick; Alinari, Lapo; Li, Yong; Andreeff, Michael; Xu, Bing; Young, Ken H
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2020
文献求助 收藏

Apatinib exhibits anti-leukemia activity in preclinical models of acute lymphoblastic leukemia

阿帕替尼在急性淋巴细胞白血病的临床前模型中表现出抗白血病活性

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-018-1421-y
Deng, Manman; Zha, Jie; Jiang, Zhiwu; Jia, Xian; Shi, Yuanfei; Li, Peng; Chen, Xiao Lei; Fang, Zhihong; Du, Zhiqiang; Xu, Bing
白血病
细胞生物学
发表日期：2018
文献求助 收藏

Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2

双硫仑/铜通过同时诱导ROS-JNK并抑制NF-κB和Nrf2，在体外和体内选择性地清除AML白血病干细胞。

期刊:Cell Death & Disease
影响因子:9.6
doi:10.1038/cddis.2017.176
Xu, Bing; Wang, Shiyun; Li, Rongwei; Chen, Kai; He, Lingli; Deng, Manman; Kannappan, Vinodh; Zha, Jie; Dong, Huijuan; Wang, Weiguang
发育与干细胞
NF-κB
白血病
JNK
干细胞
细胞生物学
发表日期：2017
文献求助 收藏

Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells

西达米德与化疗药物的协同作用通过DNA损伤积累和修复缺陷诱导急性髓系白血病干细胞和祖细胞凋亡。

期刊:Clinical Epigenetics
影响因子:4.4
doi:10.1186/s13148-017-0377-8
Li, Yin; Wang, Yan; Zhou, Yong; Li, Jie; Chen, Kai; Zhang, Leisi; Deng, Manman; Deng, Suqi; Li, Peng; Xu, Bing
发育与干细胞
凋亡
表观遗传
白血病
干细胞
细胞生物学
毒理研究
发表日期：2017
文献求助 收藏

Heterogeneity of CD34 and CD38 expression in acute B lymphoblastic leukemia cells is reversible and not hierarchically organized

急性B淋巴母细胞白血病细胞中CD34和CD38表达的异质性是可逆的，且不呈层级结构。

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-016-0310-1
Jiang, Zhiwu; Deng, Manman; Wei, Xinru; Ye, Wei; Xiao, Yiren; Lin, Simiao; Wang, Suna; Li, Baiheng; Liu, Xin; Zhang, Gong; Lai, Peilong; Weng, Jianyu; Wu, Donghai; Chen, Haijia; Wei, Wei; Ma, Yuguo; Li, Yangqiu; Liu, Pentao; Du, Xin; Pei, Duanqing; Yao, Yao; Xu, Bing; Li, Peng
白血病
CD34
CD3
CD38
细胞生物学
发表日期：2016
文献求助 收藏